World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
57
Citations
12717
World Ranking
3612
National Ranking
1671

Mirko Paiardini publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mirko Paiardini sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 188 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mirko Paiardini D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mirko Paiardini sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mirko Paiardini is affiliated with Emory University in the United States and works primarily in the fields of immunology, microbiology, and medicine. Their research focuses extensively on immunology, infectious diseases, and virology, with additional work in epidemiology and molecular biology.

Their research topics cover various aspects of HIV and COVID-19, including HIV research and treatment, immune cell function and interaction, T-cell and B-cell immunology, HIV/AIDS interventions, cytomegalovirus and herpesvirus research, and SARS-CoV-2 and COVID-19 studies.

Mirko Paiardini has published in numerous scientific venues, frequently contributing to the Journal of Virology, PLoS Pathogens, bioRxiv (Cold Spring Harbor Laboratory), UNC Libraries, and Nature Communications.

Recent publications include:

  • "Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021" (2021, Nature Medicine)
  • "Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques" (2020, Cell)
  • "Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells" (2020, Nature)
  • "Recommendations for measuring HIV reservoir size in cure-directed clinical trials" (2020, Nature Medicine)
  • "CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption" (2020, Nature Medicine)

Mirko Paiardini frequently collaborates with several researchers, including Guido Silvestri, Justin Harper, Steven E. Bosinger, Deanna A. Kulpa, and Jacob D. Estes.

Best Publications

  • Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

    Guido Silvestri;Donald L. Sodora;Richard A. Koup;Richard A. Koup;Mirko Paiardini

  • Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections

    Jason M. Brenchley;Mirko Paiardini;Kenneth S. Knox;Kenneth S. Knox;Ava I. Asher

  • Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections

    Jacob D. Estes;Levelle D. Harris;Nichole R. Klatt;Brian Tabb

  • HIV-associated chronic immune activation

    Mirko Paiardini;Michaela Müller-Trutwin

  • Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys

    Steven E. Bosinger;Qingsheng Li;Shari N. Gordon;Nichole R. Klatt

  • Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

    Steven G. Deeks;Nancie Archin;Paula Cannon;Simon Collins

  • Natural SIV Hosts: Showing AIDS the Door

    Ann Chahroudi;Ann Chahroudi;Steven Bosinger;Thomas Howerton Vanderford;Mirko Paiardini;Mirko Paiardini

  • Severe Depletion of Mucosal CD4+ T Cells in AIDS-Free Simian Immunodeficiency Virus-Infected Sooty Mangabeys

    Shari N. Gordon;Nichole R. Klatt;Nichole R. Klatt;Steven E. Bosinger;Jason M. Brenchley

  • Downregulation of Robust Acute Type I Interferon Responses Distinguishes Nonpathogenic Simian Immunodeficiency Virus (SIV) Infection of Natural Hosts from Pathogenic SIV Infection of Rhesus Macaques

    Levelle D. Harris;Brian Tabb;Donald L. Sodora;Mirko Paiardini

  • Understanding the benign nature of SIV infection in natural hosts

    Guido Silvestri;Mirko Paiardini;Ivona Pandrea;Michael M. Lederman

  • Loss of CD127 Expression Defines an Expansion of Effector CD8+ T Cells in HIV-Infected Individuals

    Mirko Paiardini;Barbara Cervasi;Barbara Cervasi;Helmut Albrecht;Alagarraju Muthukumar

  • Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection.

    Nichole R. Klatt;Jacob D. Estes;Xiaoyong Sun;Alexandra M. Ortiz;Alexandra M. Ortiz

  • Low levels of SIV infection in sooty mangabey central memory CD4 + T cells are associated with limited CCR5 expression

    Mirko Paiardini;Barbara Cervasi;Barbara Cervasi;Elane Reyes-Aviles;Luca Micci;Luca Micci

  • CD8+ Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy

    Emily K. Cartwright;Lori Spicer;S. Abigail Smith;David Lee

  • Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.

    Timothy N. Hoang;Maria Pino;Arun K. Boddapati;Elise G. Viox

  • Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells.

    Julia Bergild McBrien;Maud Mavigner;Lavinia Franchitti;S. Abigail Smith

  • CD8+ Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells

    Nichole R. Klatt;Nichole R. Klatt;Emi Shudo;Alex M. Ortiz;Jessica C. Engram

  • Mucosal immune dysfunction in AIDS pathogenesis.

    Mirko Paiardini;Ian Frank;Ivona Pandrea;Cristian Apetrei

  • CTLA-4+PD-1− Memory CD4+ T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques

    Colleen S. McGary;Claire Deleage;Justin Harper;Luca Micci

  • CD127 and CD25 Expression Defines CD4+ T Cell Subsets That Are Differentially Depleted during HIV Infection

    Richard M. Dunham;Barbara Cervasi;Jason M. Brenchley;Helmut Albrecht

  • Disruption of Intestinal CD4+ T Cell Homeostasis Is a Key Marker of Systemic CD4+ T Cell Activation in HIV-Infected Individuals

    Shari N. Gordon;Barbara Cervasi;Barbara Cervasi;Pamela Odorizzi;Randee Silverman

Frequent Co-Authors

Guido Silvestri
Guido Silvestri Emory University
Jacob D. Estes
Jacob D. Estes Oregon Health & Science University
Ann Chahroudi
Ann Chahroudi Emory University
Steven E. Bosinger
Steven E. Bosinger Emory University
Donald L. Sodora
Donald L. Sodora Seattle Children's Hospital
Mauro Magnani
Mauro Magnani University of Urbino
Jason M. Brenchley
Jason M. Brenchley National Institute of Allergy and Infectious Diseases
Cristian Apetrei
Cristian Apetrei University of Pittsburgh
Cynthia A. Derdeyn
Cynthia A. Derdeyn University of Washington
Ronald G. Collman
Ronald G. Collman University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees online can open diverse career opportunities in research, clinical practice, and patient care. Many professionals begin by exploring online BSN programs for non nurses, which are designed to help individuals without a nursing background transition into the nursing field efficiently.

Accelerated programs are particularly popular for their ability to fast-track education. Options like accelerated nurse practitioner programs offer nurses the chance to quickly advance their credentials and specialize further, often integrating immunological knowledge into clinical practice.

For those seeking easier entry points into nursing, understanding the landscape of the easiest accelerated nursing programs to get into can provide a practical pathway. Meanwhile, aspiring nurses who want to start with foundational training may consider LPN schools easy to get into, which allow quicker entry into the workforce and an opportunity to build clinical skills.

Exploring these related degrees supports a broad understanding of immunological principles within healthcare, paving the way for rewarding and impactful careers.

Best Scientists Citing Mirko Paiardini

Trending Scientists

Recently Published Articles